DP
Diadema Partners Portfolio holdings
AUM
$161M
This Quarter Return
-0.06%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$125M
AUM Growth
+$125M
(+41%)
Cap. Flow
+$38M
Cap. Flow
% of AUM
30.38%
Top 10 Holdings %
Top 10 Hldgs %
68.21%
Holding
117
New
20
Increased
17
Reduced
6
Closed
31
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$18.9M |
| 2 |
Eli Lilly
LLY
|
$15.9M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$9M |
| 4 |
Neurocrine Biosciences
NBIX
|
$6.88M |
| 5 |
argenx
ARGX
|
$6.78M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$9.05M |
| 2 |
AbbVie
ABBV
|
$8.89M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$6.68M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$5.6M |
| 5 |
AstraZeneca
AZN
|
$3.93M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Utilities | 0% |
